您的位置: 首页 > 2023年1月 第54卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

临床研究中的多重检验

Multiple testing in clinical research

来源期刊: 广州医药 | 11-15 发布时间:2023-02-07 收稿时间:2025/11/13 18:39:49 阅读量:17
作者:
关键词:
多重检验多重校正总体错误率错误发现率
multiple testingmultiple correctionfalse discovery ratefamily-wise error rate
DOI:
10.3969/j.issn.1000-8535.2023.01.002
收稿时间:
2022-07-14 
修订日期:
 
接收日期:
 
引用总数:
2  
临床研究中,我们会经常遇到多重检验的问题。当同时检验多个假设时,如何控制犯Ⅰ类错误的概率,保证结果的准确性,是研究者面对的首要问题。然而未对多重检验进行校正的文章比例仍较大。本文从简单的单个检验假设出发,回答为什么需要进行多重校正,何时进行多重校正,同时介绍总体错误率(FWER)和错误发现率(FDR)两种重要的错误率以及在此基础上的Bonferroni和Benjamini-Hochberg校正方法,从而避免因多重检验问题带来的混乱。
In clinical research, we often encounter the problem of multiple testing. When testing many hypotheses at the same time, how to control the type I error to ensure the accuracy of the results is the primary problem faced by researchers. However, the proportion of articles that didn't correct the multiple testing remains substantial. Starting with the simple hypothesis of a single test, this article provides an introduction to multiple testing issues, answers why and when multiple corrections are needed, introduces two important error rates which are family-wise error rate (FWER) and false discovery rate (FDR), and the Bonferroni and Benjamini-Hochberg correction methods based on them, thereby avoiding confusion caused by multiple testing.
1、 ALOSH M, BRETZ F, HUQUE M. Advanced multiplicity adjustment methods in clinical trials[J]. Stat Med,2014,33(4):693-713. ALOSH M, BRETZ F, HUQUE M. Advanced multiplicity adjustment methods in clinical trials[J]. Stat Med,2014,33(4):693-713.
2、 JONES H E, OHLSSEN D I, SPIEGELHALTER D J. Use of the false discovery rate when comparing multiple health care providers[J]. J Clin Epidemiol,2008,61(3):232-240. JONES H E, OHLSSEN D I, SPIEGELHALTER D J. Use of the false discovery rate when comparing multiple health care providers[J]. J Clin Epidemiol,2008,61(3):232-240.
3、 PERNEGER T V. What's wrong with Bonferroni adjustments[J]. BMJ,1998,316(7139):1236-1238. PERNEGER T V. What's wrong with Bonferroni adjustments[J]. BMJ,1998,316(7139):1236-1238.
4、 LUDBROOK J. Repeated measurements and multiple comparisons in cardiovascular research[J]. Cardiovasc Res,1994,28(3):303-311. LUDBROOK J. Repeated measurements and multiple comparisons in cardiovascular research[J]. Cardiovasc Res,1994,28(3):303-311.
5、 WALLENTIN L, BECKER R C, BUDAJ A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med,2009,361(11):1045-1057. WALLENTIN L, BECKER R C, BUDAJ A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med,2009,361(11):1045-1057.
6、 GLICKMAN M E, RAO S R, SCHULTZ M R. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies[J]. J Clin Epidemiol,2014,67(8):850-857. GLICKMAN M E, RAO S R, SCHULTZ M R. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies[J]. J Clin Epidemiol,2014,67(8):850-857.
7、 BENDER R, LANGE S. Adjusting for multiple testing-when and how?[J]. J Clin Epidemiol, 2001,54(4):343-349. BENDER R, LANGE S. Adjusting for multiple testing-when and how?[J]. J Clin Epidemiol, 2001,54(4):343-349.
8、 WASON J M, STECHER L, MANDER A P. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?[J]. Trials,2014(15):364. WASON J M, STECHER L, MANDER A P. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?[J]. Trials,2014(15):364.
9、 RANSTAM J. Multiple P-values and Bonferroni correction[J]. Osteoarthritis Cartilage,2016 ,24(5):763-764. RANSTAM J. Multiple P-values and Bonferroni correction[J]. Osteoarthritis Cartilage,2016 ,24(5):763-764.
10、 LI G, TALJAARD M, van den HEUVEL E R, et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how[J]. Int J Epidemiol, 2017,46(2):746-755. LI G, TALJAARD M, van den HEUVEL E R, et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how[J]. Int J Epidemiol, 2017,46(2):746-755.
1、孙芳.舌三针对幕下卒中后吞咽障碍患者的大脑可塑性影响研究[D].广州中医药大学,2024.DOI:10.27044/d.cnki.ggzzu.2024.000043. 孙芳.舌三针对幕下卒中后吞咽障碍患者的大脑可塑性影响研究[D].广州中医药大学,2024.DOI:10.27044/d.cnki.ggzzu.2024.000043.
2、卫彩红.巴楚马鞍菌与宿主植物的关系及其荒漠共生系统研究[D].塔里木大学,2025.DOI:10.27708/d.cnki.gtlmd.2025.000005. 卫彩红.巴楚马鞍菌与宿主植物的关系及其荒漠共生系统研究[D].塔里木大学,2025.DOI:10.27708/d.cnki.gtlmd.2025.000005.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录